№ files_lp_4_process_2_57650
File format: docx
Character count: 14361
File size: 49 KB
A healthcare source providing guidance for patients on identifying, preventing, and managing blood clots associated with cancer treatment.
Departments:
Oncology, Haematology
Date written:
08/06/2022
Last reviewed:
07/08/2024
Next review date:
06/08/2026
Type of document:
Patient information leaflet
Target audience:
Patients with cancer
Medical focus:
Cancer-associated thrombosis and blood clot management
Treatment methods:
Anticoagulants (injections and tablets)
Symptoms described:
Deep vein thrombosis, pulmonary embolism
Risks mentioned:
Side effects of anticoagulants, bleeding, bruising
Instructions:
When to seek medical attention, monitoring for symptoms
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
International / Multiple research institutions
Subject:
Cancer immunotherapy, tumor microenvironment
Document type:
Supplementary scientific data
Institution:
University of Southampton, Genkyotex SA, La Jolla Institute for Allergy & Immunology, University of Toronto, University of Kent
Authors:
Kirsty Ford, Christopher J. Hanley, Massimiliano Mellone, Cedric Szyndralewiez, Freddy Heitz, Philippe Wiesel, Oliver Wood, Maria Machado, Monette Lopez, Anusha-Preethi Ganesan, Chuan Wang, Ankur Chakravarthy, Tim Fenton, Emma V. King, Pandurangan Vijayanand, Christian H. Ottensmeier, Aymen Al-Shamkhani, Natalia Savelyeva, Gareth J. Thomas
Target audience:
Researchers in oncology and immunology
Data type:
Figures, tables, and experimental results
Methods:
Q-PCR, immunofluorescence, IHC, RNA sequencing, gene network analysis
Experimental models:
Murine syngeneic tumors, TC1, MC38, 4T1, BALBneuT breast tumors
Treatment tested:
NOX4 inhibition, TGF-β1 inhibition, αPD-1, αCTLA-4, macrophage depletion
Key focus:
CAF-mediated CD8 T-cell exclusion, tumor growth modulation, immunotherapy response
Supplementary content:
Figures S1–S6, Tables S1–S2
Year:
2020
Region / City:
Sweden
Topic:
Medical Research, Thrombosis Prevention
Document Type:
Research Study Protocol
Organization / Institution:
Karolinska Institute
Author:
Paul Ackermann, Simon Svedman, Luigi Belcastro
Target Audience:
Medical Professionals, Researchers
Duration:
6-8 weeks for patients, study duration unspecified
Approval Date:
2020-03-25
Modification Date:
None
Funding:
Swedish Research Council
Primary Investigator:
Paul Ackermann
Clinical Trial Registration:
NCT03259204
Web:
https://ki.se/mmk/stop-leg-clots
Description:
A multicenter clinical trial to assess the impact of mechanical blood clot prevention on reducing deep vein thrombosis (DVT) risk in leg-immobilized outpatients.
Year:
2023
Region / City:
Utah
Subject:
Anti-thrombotic therapy management
Document Type:
Policy
Institution:
UUH
Author:
UUH Pharmacy Department
Target Audience:
Healthcare providers, pharmacists, medical and pharmacy students, residents
Period of validity:
Ongoing, reviewed annually
Approval Date:
Not specified
Amendment Date:
Not specified
Unique Identifier:
[Category]
Document Type:
Clinical Guideline
Risk of non-compliance:
May result in significant harm to the patient/Te Whatu Ora
Function:
Clinical Practice, Patient Care
User Group(s):
Te Toka Tumai Auckland only
Organisation(s):
Te Whatu Ora | Te Toka Tumai Auckland
Directorate(s):
Surgical Services, Adult Medical Services
Department(s):
Liver Transplant Unit
Used for which patients?:
Patients managed by the Hepatology/Liver Transplant team
Author:
Hannah Giles (ADHB)
Edited by:
Document Control
Review frequency:
3 yearly
Scope:
Management of non tumoural porto-mesenteric vein thrombosis
Clinical focus:
Recanalisation, anticoagulation, TIPSS, management of varices
Population:
Adult patients under hepatology and liver transplant services
Year:
2016/17
Region / city:
Wandsworth
Topic:
Healthcare Services, Clinical IT, Medical Guidelines
Document Type:
Guidelines
Target Audience:
Healthcare professionals, medical staff
Effective Period:
2016-2017
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2021
Journal:
World Journal of Clinical Cases
Volume:
9
Issue:
36
Pages:
11495–11503
DOI:
10.12998/wjcc.v9.i36.11495
Publisher:
Baishideng Publishing Group Inc.
Document Type:
Case report
Academic Field:
Clinical medicine; Hepatic surgery; Oncology
Medical Topic:
Hepatocellular carcinoma with tumor thrombosis in inferior vena cava
Authors:
Zun-Yi Zhang; Er-Lei Zhang; Bi-Xiang Zhang; Wei Zhang
Affiliation:
Research Laboratory and Hepatic Surgery Center, Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Institution Location:
Wuhan, Hubei Province, China
Corresponding Author:
Wei Zhang
Submission Date:
August 19, 2021
Revision Date:
September 25, 2021
Acceptance Date:
November 14, 2021
Online Publication Date:
December 26, 2021
Funding:
National Natural Science Foundation of China (No. 81802767; No. 81860117)
Patient Characteristics:
47-year-old woman with chronic hepatitis B and hepatocellular carcinoma
Clinical Intervention:
Right major hepatectomy with tumor thrombectomy under cardiopulmonary bypass followed by sorafenib therapy
Follow-up Period:
11 months
Outcome:
No recurrence detected during follow-up
Year:
2023-2024
Field:
Vascular Biology and Thrombosis Research
Type of document:
Award Announcement / Application Form
Sponsor:
Bernd R. Binder
Target audience:
First authors of original research articles
Submission deadline:
June 30, 2025
Award date:
October 22, 2025
Location of award ceremony:
Prague, Czech Republic
Award amount:
€2,500 per prize
Included benefits:
Free registration at ECTH Congress, travel cost reimbursement
Publication requirement:
Peer-reviewed international journal article
Application requirements:
Signed application form, PDF of paper, brief CV, description of significance, co-author consent
Year:
2026
Region / City:
Global
Subject:
Cardiovascular pathology
Document Type:
Educational quiz / clinical review
Institution:
Medical education resource
Target Audience:
Medical students, healthcare professionals
Key Terms:
Thrombosis, embolism, edema, myocardial infarction, congestion, hemorrhage
Clinical Focus:
Heart failure, vascular disorders, systemic and pulmonary circulation
Format:
Multiple-choice questions with answer options
Source Type:
Academic/educational material
Contextual Description:
Multiple-choice clinical and pathological quiz questions addressing the mechanisms, types, and consequences of thrombosis, embolism, edema, hemorrhage, and related cardiovascular complications.